Evaluation of serum anti-Mullerian hormone levels to assess the ovarian reserve in women with severe endometriosis
- 1 January 2014
- journal article
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 172, 62-64
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Pathogenesis and pathophysiology of endometriosisFertility and Sterility, 2012
- Cellular and molecular basis for endometriosis-associated infertilityCell and tissue research, 2012
- Measuring anti-Müllerian hormone for the assessment of ovarian reserve: When and for whom is it indicated?Maturitas, 2012
- Surgical measures for endometriosis-related infertility: A plea for researchPlacenta, 2011
- Deep pelvic endometriosis negatively affects ovarian reserve and the number of oocytes retrieved for in vitro fertilizationActa Obstetricia et Gynecologica Scandinavica, 2011
- Serum anti-Müllerian hormone is a better predictor of ovarian response than FSH and age in IVF patients with endometriosisClinical and Experimental Reproductive Medicine, 2011
- Serum antimüllerian hormone concentrations on day 3 of the in vitro fertilization stimulation cycle are predictive of the fertilization, implantation, and pregnancy in polycystic ovary syndrome patients undergoing assisted reproductionFertility and Sterility, 2010
- Human Ovarian Reserve from Conception to the MenopausePLOS ONE, 2010
- Anti muellerian hormone serum levels in women with endometriosis: A case–control studyGynecological Endocrinology, 2009
- Endometriosis and Inflammation in InfertilityAnnals of the New York Academy of Sciences, 2004